Janus Henderson Horizon Biotechnology Fund GU2 HEUR
WKN A40QHN | ISIN LU2900275277 | Fonds
Fonds
ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
---|---|---|---|---|---|---|
1 | LU1897414642 | Janus Henderson Horizon Biotechnology Fund E2 USD | -6,57 % | +27,59 % | -0,32 |
|
2 | LU1540961759 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD | -4,06 % | +18,70 % | -0,34 |
|
3 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -4,77 % | +20,45 % | -0,34 |
|
4 | LU1897414568 | Janus Henderson Horizon Biotechnology Fund IU2 USD | -7,34 % | +27,88 % | -0,34 |
|
5 | LU1540962054 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD | -4,55 % | +19,53 % | -0,35 |
|
79 | LU0415392249 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating | -12,22 % | +12,91 % | -1,12 |
|
80 | DE000A3DCA95 | BIT Biotech Opportunities S | -35,90 % | +30,91 % | -1,23 |
|
81 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -36,10 % | +30,90 % | -1,24 |
|
82 | LU0415392835 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | -15,46 % | +13,82 % | -1,28 |
|
83 | LU0415392595 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | -16,05 % | +13,82 % | -1,33 |
|